Education, Training, Board Certifications
- MD, Washington University School of Medicine
- PhD, Washington University School of Medicine
- Residency, Barnes Jewish Hospital, Washington University School of Medicine
- Fellowship in Oncology, UW/Fred Hutch
- Medical Oncology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Clinical Expertise
Affiliations
Publications
Research and/or clinical interests
Dr. Scott Tykodi specializes in translating immunotherapy advances from the laboratory into the clinic. He has led numerous clinical trials evaluating novel, immune-based therapeutics for patients with kidney cancer and other solid tumors. Dr. Tykodi is developing a new cellular immunotherapy for kidney cancer aimed at a marker called 5T4, which is found on the surface of almost all kidney cancer cells and only rarely on healthy adult cells.
